Supexa-OD 15 Tablet
Rs 380 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Supexa-OD 15 Tablet
Supexa-OD 15 Tablet is an oral anticoagulant indicated to prevent stroke and blood clots in nonvalvular atrial fibrillation and treat deep vein thrombosis and pulmonary embolism. It inhibits Factor Xa, an essential enzyme in the formation of a clot. For maximum protection against stroke or clot recurrence, Supexa-OD 15 Tablet should be taken as directed, at the same time each day. Stopping the medication abruptly or skipping doses could raise the risk of dangerous blood clots. When a dose is forgotten, take it as soon as possible on the same day, but avoid doubling up. Follow-up visits and checks for signs of bleeding or clotting should be conducted during therapy. Common side effects of Supexa-OD 15 Tablet include bleeding, rash, anemia, and increased liver tests. If you have concerns about these effects or experience any unusual symptoms, consult your doctor for guidance. Supexa-OD 15 Tablet is contraindicated in patients with pathologically active bleeding, including gastrointestinal bleeding or recent hemorrhagic stroke. It must not be administered in patients with a mechanical heart valve or in moderate to severe mitral stenosis since it is not established in its safety and effectiveness in these conditions. Caution is exercised in patients with severe renal impairment or hepatic illness with coagulopathy, in whom bleeding risk is higher. Supexa-OD 15 Tablet must not also be started in patients with CrCl >95 mL/min when given for nonvalvular atrial fibrillation, as a decrease in the efficacy of preventing stroke exists.
Product Highlights and Usage:
Uses: Prevention of Deep vein thrombosis | Prevention of Pulmonary embolism | Stroke prevention Benefits: Prevention of Deep vein thrombosis Deep vein thrombosis is the formation of blood clots in deep veins, usually in the legs. These clots can cause swelling, pain, and may travel to the lungs, leading to serious complications. After an initial course of injectable anticoagulants, Supexa-OD 15 Tablet is used to help prevent new clots and reduce the chances of DVT recurrence. Prevention of Pulmonary embolism Pulmonary embolism occurs when a blood clot blocks an artery in the lungs, often originating from a DVT. This can lead to chest pain, breathing difficulty, and even be life-threatening. Supexa-OD 15 Tablet, after initial injectable therapy, works by preventing further clot formation, reducing the risk of recurrent PE, and supporting safer recovery. Stroke prevention Some strokes are caused by blood clots that form due to an irregular heartbeat not related to heart valve problems (nonvalvular atrial fibrillation, or NVAF). Supexa-OD 15 Tablet is used to prevent these types of strokes by reducing the risk of clot formation in the blood.
How it works:
Supexa-OD 15 Tablet is a direct oral anticoagulant (DOAC) that acts to selectively block Factor Xa, a central enzyme involved in the coagulation cascade of the blood. Inhibiting Factor Xa prevents the conversion of prothrombin into thrombin, which is required for clot formation. This prevents the formation of dangerous blood clots in diseases such as nonvalvular atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Its targeted action ensures effective anticoagulation with consistent outcomes and fewer risks of specific bleeding complications than conventional blood thinners.
Directions for use:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Supexa-OD 15 Tablet may be taken with or without food.
Warning & Precaution:
Safety Advice: Alcohol: It is not known whether it is safe to consume alcohol with Supexa-OD 15 Tablet. Please consult your doctor. Pregnancy: Supexa-OD 15 Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks. Breast feeding: Information regarding the use of Supexa-OD 15 Tablet during breastfeeding is not available. Please consult your doctor. Driving: Supexa-OD 15 Tablet does not usually affect your ability to drive. Kidney: Supexa-OD 15 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment may be needed. Liver: Supexa-OD 15 Tablet should be used with caution in patients with liver disease. Dose adjustment may be needed. Side Effects: Increased bleeding tendency | Rash | Abnormal liver function tests | Anemia (low number of red blood cells)
TEsa
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
66.2$
-
84.38$